LEADER 01902nam  2200577Ia 450 
001 9910783285603321
005 20230617023826.0
010   $a0-309-16604-7
010   $a1-280-17604-0
010   $a9786610176045
010   $a0-309-53275-2
035   $a(CKB)1000000000018438
035   $a(EBL)3377402
035   $a(SSID)ssj0000176894
035   $a(PQKBManifestationID)11156180
035   $a(PQKBTitleCode)TC0000176894
035   $a(PQKBWorkID)10209622
035   $a(PQKB)11162134
035   $a(MiAaPQ)EBC3377402
035   $a(Au-PeEL)EBL3377402
035   $a(CaPaEBR)ebr10071429
035   $a(CaONFJC)MIL17604
035   $a(OCoLC)923270351
035   $a(EXLCZ)991000000000018438
100   $a20040929d2004      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aImmunization safety review$b[electronic resource] $evaccines and autism /$fImmunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$dc2004
215   $a1 online resource (199 p.)
300   $aDescription based upon print version of record.
311   $a0-309-09237-X 
320   $aIncludes bibliographical references.
606   $aVaccination$xComplications
606   $aAutism
615  0$aVaccination$xComplications.
615  0$aAutism.
676   $a614.4
701   $aRogers$b Bonnie$01507651
712 02$aInstitute of Medicine (U.S.).$bBoard on Health Promotion and Disease Prevention.
712 02$aInstitute of Medicine (U.S.).$bImmunization Safety Review Committee.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910783285603321
996   $aImmunization safety review$93738557
997   $aUNINA